This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Resolved

JAMP BRIMONIDINE

JAMP PHARMA CORPORATION

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP BRIMONIDINE in Canada?

Yes. JAMP BRIMONIDINE 0.2% has an active shortage reported to Health Canada (last updated October 30, 2026).

Why is JAMP BRIMONIDINE not available?

The reason the manufacturer reported: Demand increase for the drug.

When will JAMP BRIMONIDINE be available again?

The manufacturer's estimated resolution date is February 5, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength0.2%

Report last updated2026-07-31

Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02449226

Strength

0.2%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BRIMONIDINE TARTRATE

Tier

Unrated

Last Updated

2026-07-31

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

JAMP BRIMONIDINE has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-30

Active Shortage

Demand increase for the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225